VHL and nonpapillary renal cell carcinoma: ccRCC is distinguished by inactivating mutations in VHL (von Hippel-Lindau tumor suppressor), leading to constitutive activation of the hypoxia-inducible factors (HIFs) and induction of a hypoxia response transcription signature.